| HOME >> MEDICINE >> TECHNOLOGY |
Table 9: Key Pipeline Drugs of GSK, 2009 150
Table 10: Top Selling Drugs of Novartis, Sales Value ($m), 2009 151
Table 11: Key Pipeline Drugs Of Novartis, 2009 152
Table 12: Top Selling Drugs of Sanofi-Aventis, Sales Value ($m), 2009 153
Table 13: Key Pipeline drugs of Sanofi-Aventis, 2009 155
Table 14: Top Selling Drugs of AstraZeneca, Sales Value ($m), 2009 156
Table 15: Key Pipeline Drugs of AstraZeneca, 2009 158
Table 16: Top Selling Drugs of Merck ,Sales Value ($m), 2009 160
Table 17: Key Pipeline Drugs of Merck, 2009 161
Table 18: Top Selling Drugs of Bayer HealthCare, Sales Value ($m), 2009 162
Table 19: Key Pipeline Drugs of Bayer, 2009 163
Table 20: BLAs Approved by FDA in 2009 164
Table 21: NME Approved by FDA in 2009 165
Table 22: Key Warning Letters by FDA to Pharmaceutical Companies, 2009 168
Table 23: Key Drug Approvals by EMA in 2009 169
Table 24: Key NDA and Drug Approvals by MHLW, Japan, 2009 1711.2
List of FiguresFigure 1: Global Pharmaceutical Market, Market Share of Top Manufacturers(%), 2009 13
Figure 2: Global Pharmaceutical Industry, Market Share by Therapeutic Area, Global, Sales Value(%), 2009 14
Figure 3: Cardiovascular Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 17
Figure 4: Cardiovascular Therapeutics ,Global, Market Share by Indication(%), 2009 and 2016 18
Figure 5: Cardiovascular Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 18
Figure 6: Cardiovascular Therapeutics Market, Global, M&A Deals by Geography, 2009 -2010 21
Figure 7: Cardiovascular Therapeutics Market, Global, M&A Deals by Value ($), 2009-2010 22
Figure 8: Respiratory Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009 23
Figure 9: Respiratory Therapeutics ,Global, Mar
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |